SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-169619
Filing Date
2017-05-15
Accepted
2017-05-15 07:34:56
Documents
3
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d399201d8k.htm 8-K 16266
2 EX-99.1 d399201dex991.htm EX-99.1 56849
3 GRAPHIC g399201g0513072624724.jpg GRAPHIC 2659
  Complete submission text file 0001193125-17-169619.txt   78226
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 17841075
SIC: 2834 Pharmaceutical Preparations